Impact of Tumor Oxygen Levels on Survival in Soft Tissue Sarcomas
Author Information
Author(s): Nordsmark M, Alsner J, Keller J, Nielsen O S, Jensen O M, Horsman M R, Overgaard J
Primary Institution: Danish Cancer Society Department of Experimental Clinical Oncology and Departments of Oncology, Orthopaedic Surgery and Pathology, Aarhus University Hospital, Denmark
Hypothesis
Does tumor hypoxia affect survival outcomes in soft tissue sarcomas and is there an association with p53 mutations?
Conclusion
Hypoxia is linked to poorer survival outcomes in soft tissue sarcomas, but there is no association with p53 mutations.
Supporting Evidence
- Tumor hypoxia was associated with poorer disease-specific and overall survival.
- Only 6 tumors had functional p53 mutations, showing no link to hypoxia.
- Lower histopathological grade tumors were well-oxygenated compared to high-grade tumors.
Takeaway
If a tumor doesn't get enough oxygen, it can make it harder for patients to survive, but having a certain gene mutation (p53) doesn't seem to matter.
Methodology
Tumor oxygenation measurements were taken from biopsies and analyzed for their impact on survival.
Limitations
The study had a small sample size and only a few tumors with p53 mutations.
Participant Demographics
Patients with soft tissue sarcomas, median follow-up of 74 months.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website